The Cytokine Release Syndrome Market represents a crucial domain within the biopharmaceutical industry, propelled by remarkable advancements in immunotherapy and cell-based oncology treatments. Cytokine Release Syndrome manifests as a widespread inflammatory response that can emerge after particular cancer therapies, notably CAR-T cell interventions and monoclonal antibody administrations. As...